Detalhe da pesquisa
1.
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force.
Mult Scler
; 30(3): 396-418, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38140852
2.
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
Pharmacoepidemiol Drug Saf
; 30(3): 334-341, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33099846
3.
Imposed registries within the European postmarketing surveillance system: Extended analysis and lessons learned for regulators.
Pharmacoepidemiol Drug Saf
; 27(7): 823-826, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29749086
4.
Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making.
Clin Pharmacol Ther
; 113(1): 135-151, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36254408
5.
Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency.
Eur Heart J Qual Care Clin Outcomes
; 9(2): 109-118, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746430
6.
Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources Database.
Drug Saf
; 45(7): 747-754, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729468
7.
Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe.
Front Pharmacol
; 13: 924648, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35991868
8.
Marketing Authorization Applications Made to the European Medicines Agency in 2018-2019: What was the Contribution of Real-World Evidence?
Clin Pharmacol Ther
; 111(1): 90-97, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34689339
9.
Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe.
Drug Saf
; 45(10): 1069-1081, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001288
10.
Correction to: Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
Drug Saf
; 42(11): 1353, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31489581
11.
Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
Drug Saf
; 42(11): 1343-1351, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31302896
12.
EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making.
BMJ Open
; 8(6): e021864, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903798
13.
Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation.
BMJ Open
; 8(9): e023090, 2018 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185579
14.
Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".
Drug Saf
; 42(12): 1517-1518, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31552604